Breaking News Instant updates and real-time market news.

MLNX

Mellanox

$65.10

0.8 (1.24%)

, PBCT

People's United

$19.43

-0.02 (-0.10%)

17:24
01/18/18
01/18
17:24
01/18/18
17:24

On The Fly: After Hours Movers

UP AFTER EARNINGS: Mellanox (MLNX), up 6%... People's United Financial (PBCT), up 1.3%. ALSO HIGHER: GWG Holdings (GWGH), up 4.7% after it announced a partnership with the Beneficient Company... Corbus Pharmaceuticals (CRBP), up 3.1% after the stock was initiated with an Outperform rating at Raymond James. DOWN AFTER EARNINGS: IBM (IBM), down 3.7%... American Express (AXP), down 2.4%.

MLNX

Mellanox

$65.10

0.8 (1.24%)

PBCT

People's United

$19.43

-0.02 (-0.10%)

GWGH

GWG Holdings

$8.10

-0.2 (-2.41%)

CRBP

Corbus Pharmaceuticals

$7.95

-0.25 (-3.05%)

IBM

IBM

$169.12

0.47 (0.28%)

AXP

American Express

$99.86

-0.9 (-0.89%)

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

MLNX Mellanox
$65.10

0.8 (1.24%)

12/07/17
STFL
12/07/17
NO CHANGE
Target $70
STFL
Buy
Mellanox price target raised to $70 from $53 at Stifel
Stifel analyst Kevin Cassidy raised his price target on Mellanox to $70 from $53 as he projected the earnings improvement potential from the operational changes that may be prompted by the involvement of activist investor Starboard Value. If Mellanox' 2018 SG&A spending came in line with peers, it could increase 2018 non-GAAP EPS by about $1.00, estimated Cassidy, who keeps a Buy rating on the stock.
12/13/17
SUSQ
12/13/17
INITIATION
Target $75
SUSQ
Positive
Mellanox initiated with a Positive, sees restructuring/takeout at Susquehanna
Susquehanna analyst Christopher Rolland initiated Mellanox (MLNX) with a Positive and $75 price target. Rolland said Mellanox has dominated the high-speed low-latency interconnect market and envisions three scenarios for the company. First, Mellanox is bought at a 30% premium due to synergies. Second, Mellanox does a Marvell (MRVL) type restructuring to drive operating margins through "deep opex cuts." Lastly, the company organically grows 30% operating margins and sells itself to an acquirer.
01/12/18
DADA
01/12/18
NO CHANGE
Target $75
DADA
Buy
Mellanox price target raised to $75 from $70 at DA Davidson
DA Davidson analyst Mark Kelleher raised his price target on Mellanox to $75 ahead of the Q4 earnings next week. Kelleher says the company is well positioned for "solid top and bottom line growth over the next several years based on the growth of its primary revenue drivers - Infiniband and Ethernen. The analyst adds that the management is increasingly focused on operational efficiency after Starboard's activist position in the company, keeping his Buy rating on Mellanox.
12/12/17
SUSQ
12/12/17
INITIATION
Target $75
SUSQ
Positive
Mellanox initiated with a Positive at Susquehanna
Target $75.
PBCT People's United
$19.43

-0.02 (-0.10%)

06/05/17
MSCO
06/05/17
NO CHANGE
MSCO
Midcap Bank sector upgraded to In-Line at Morgan Stanley
Morgan Stanley analyst Ken Zerbe upgraded the Midcap Bank sector to In-Line from Cautious citing the group's underperformance year-to-date and better earnings from lower deposit betas. The firm's top picks are SVB Financial (SIVB), Signature Bank (SBNY), KeyBanc (KEY), and Citizens Financial (CFG). Note the analyst upgraded People's United (PBCT) and Prosperity Bancshares (PB) to Equal Weight citing valuations.
03/10/17
SDLR
03/10/17
UPGRADE
SDLR
Hold
People's United upgraded to Hold from Sell at Sandler O'Neill
Sandler O'Neill upgraded People's United to Hold with a $19.50 price target saying its asset sensitivity position should do well in a higher rate environment.
06/05/17
MSCO
06/05/17
UPGRADE
MSCO
Equal Weight
People's United upgraded to Equal Weight from Underweight at Morgan Stanley
06/05/17
06/05/17
UPGRADE

Equal Weight
People's United upgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded People's United to Equal Weight from Underweight. Analyst Ken Zerbe changed his view citing relative valuation and better-than peer underwriting track record.
GWGH GWG Holdings
$8.10

-0.2 (-2.41%)

03/22/17
MAXM
03/22/17
NO CHANGE
Target $14
MAXM
Buy
GWG Holdings price target raised to $14 from $11 at Maxim
Maxim analyst Michael Diana said GWG Holdings is on the path to reaching 1,000 unique lives insured in 2018, which he sees as a "tipping point" that should lead to more steady earnings and cash flows. Diana raised his price target on GWG to $14 from $11 and keeps a Buy rating on the shares.
03/10/17
ROTH
03/10/17
NO CHANGE
Target $15
ROTH
Buy
GWG Holdings price target raised to $15 from $10 at Roth Capital
Roth Capital analyst William Gibson raised his price target for GWG Holdings to $15 from $10 based on the "strong portfolio growth" that he expects to continue. The analyst reiterates a Buy rating on the shares.
CRBP Corbus Pharmaceuticals
$7.95

-0.25 (-3.05%)

12/14/17
CANT
12/14/17
NO CHANGE
Target $28
CANT
Overweight
Corbus Pharmaceuticals price target raised to $28 from $24 at Cantor Fitzgerald
Cantor analyst Elemer Piros raised Corbus Phamaceuticals price target to $28 from $24 following initiation of Corbus' Phase 3 RESOLVE-1 study in systemic sclerosis patients. Piros sees increased probability of success to 60% from $30% for anabasum in the indication. The analyst is encouraged by continued execution in SSc and reiterates his Overweight rating on Corbus shares.
09/29/17
09/29/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Regeneron (REGN) assumed with an Overweight at Piper Jaffray. 2. MasterCard (MA) and Visa (V) were initiated with an Overweight at Cantor Fitzgerald. 3. Liberty Global (LBTYA, LBTYK) and Liberty Global LiLAC (LILA) were initiated with a Buy at Buckingham. 4. Corbus Pharmaceuticals (CRBP) coverage assumed with a Buy at Noble Financial. 5. Medpace (MEDP) initiated with a Market Perform at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/17
NBLE
09/29/17
INITIATION
NBLE
Buy
Corbus Pharmaceuticals coverage assumed with a Buy at Noble Financial
Noble Financial analyst Caroline Palomeque assumed coverage of Corbus with a $16 price target and a Buy rating. The analyst believes that the launch of several trials of the company's Anabasum drug and the announcement of data on the drug from several other trials will be positive catalysts for the stock.
01/18/18
RAJA
01/18/18
INITIATION
Target $24
RAJA
Outperform
Corbus Pharmaceuticals initiated with an Outperform at Raymond James
Raymond James analyst Laura Chico started Corbus Pharmaceuticals with an Outperform rating and $24 price target. The analyst thinks the data support advancement of the company's lead asset lenabasum in systemic sclerosis, dermatomyositis and cystic fibrosis. She believes systemic sclerosis alone can yield fair value of $11 per share.
IBM IBM
$169.12

0.47 (0.28%)

01/17/18
LEHM
01/17/18
UPGRADE
Target $192
LEHM
Overweight
IBM upgraded to Overweight from Underweight at Barclays
Barclays analyst Mark Moskowitz double upgraded IBM (IBM) to Overweight from Underweight and raised his price target for the shares to $192 from $133. The technology giant closed yesterday up 69c to $163.85. The company could be entering a period of top-line stability and maybe even modest growth over the next 12-18 months, Moskowitz tells investors in a research note. The analyst thinks IBM could emerge over time as the next important cloud vendor after Amazon (AMZN) and Microsoft's (MSFT) Azure. Moskowitz sees room for another cloud player and thinks the "narrative can favorably shift for shares of IBM."
01/12/18
BMOC
01/12/18
NO CHANGE
Target $175
BMOC
Market Perform
IBM price target raised to $175 from $170 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on IBM to $175, reiterating that the mainframe cycle and FX trends are beginning to improve. The analyst keeps his Market Perform rating based on valuations, but suggests that the December quarter estimates could prove to be conservative. Longer term, Bachman contends that the Systems segment could generate "durable growth" and the Cognitive business can grow operating profits this year.
01/17/18
01/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IBM (IBM) upgraded to Overweight from Underweight at Barclays with analyst Mark Moskowitz saying the company could be entering a period of top-line stability and maybe even modest growth over the next 12-18 months. 2. Ulta Beauty (ULTA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying Ulta shares are trading at a compelling multiple given the company's long runway for earnings per share growth combined with benefits from lower tax rates. 3. Groupon (GRPN) upgraded to Neutral from Sell at Goldman Sachs with analyst Christopher Merwin saying stabilizing gross profit growth, coupled with cost savings, should drive upside to Street EBITDA expectations in 2018. 4. L3 Technologies (LLL) upgraded to Buy from Neutral at BofA/Merrill with analyst Ronald Epstein saying it will benefit from "upward momentum" in the U.S. defense budget. 5. Dick's Sporting (DKS) upgraded to Buy from Neutral at Buckingham with the firm citing tax reform benefits and recent strength across retail. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
WEDB
01/18/18
NO CHANGE
Target $185
WEDB
Neutral
IBM price target raised to $185 from $155 at Wedbush
Wedbush analyst Moshe Katri raised his price target for IBM to $185 from $155 on valuation. The analyst reiterates a Neutral rating on the shares.
AXP American Express
$99.86

-0.9 (-0.89%)

01/11/18
NOMU
01/11/18
NO CHANGE
Target $108
NOMU
Neutral
American Express likely to suspend buyback, says Nomura Instinet
After speaking with investors, Nomura Instinet analyst Bill Carcache believes the capital impact on American Express from tax reform is not well understood. He estimates the tax reform charge will bring the company's CET1 ratio to 9.2% in Q4. The analyst believes, however, that American Express needs to maintain a CET1 level of no less than 11% if it is to pass the Federal Reserve's stress tests and sustain its buyback program. As such, he thinks the company will likely to suspend its buyback program in the first half of 2018. Carcache lowered his estimates and expects the stock to underperform in 2018. He believes other card issuers are better positioned to reinvest tax savings into growth. The analyst reduced his price target for American Express shares to $108 from $110 and keeps a Neutral rating on the name.
01/12/18
JPMS
01/12/18
DOWNGRADE
Target $105
JPMS
Neutral
American Express downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Richard Shane downgraded American Express to Neutral with an unchanged price target of $105 citing valuation.
01/09/18
WELS
01/09/18
NO CHANGE
Target $115
WELS
Outperform
American Express price target raised to $115 from $105 at Wells Fargo
Wells Fargo analyst Donald Fandetti raised his price target for American Express to $115 from $105 as he believes the U.S. consumer remains quite healthy and the tax cuts could provide a slight tailwind. The analyst reiterates an Outperform rating on the shares.
01/02/18
DBAB
01/02/18
INITIATION
Target $118
DBAB
Buy
American Express initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Ashish Sabadra initiated American Express with a Buy rating and a price target of $118. Sabadra contends that accelerated small business growth, proprietary card use in the international segment, and co-brand wins in the U.S. suggest that the company's business model remains intact. The analyst also notes that moderating rewards competition and cost discipline will support American Express earnings power.

TODAY'S FREE FLY STORIES

PEG

PSEG

$49.18

0.65 (1.34%)

, COG

Cabot Oil & Gas

$23.88

0.63 (2.71%)

20:25
02/22/18
02/22
20:25
02/22/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PEG

PSEG

$49.18

0.65 (1.34%)

COG

Cabot Oil & Gas

$23.88

0.63 (2.71%)

HUN

Huntsman

$33.32

-0.27 (-0.80%)

CNK

Cinemark

$39.72

0.1 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 05

    Mar

  • 23

    May

DOVA

Dova Pharmaceuticals

$32.78

-0.08 (-0.24%)

19:57
02/22/18
02/22
19:57
02/22/18
19:57
Syndicate
Dova Pharmaceuticals 2.5M share Secondary priced at $32.00 »

JPMorgan, Jefferies and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    Feb

SPY

SPDR S&P 500 ETF Trust

$270.40

0.35 (0.13%)

, SPX

S&P 500

19:25
02/22/18
02/22
19:25
02/22/18
19:25
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Treasury Sec.: Trump…

SPY

SPDR S&P 500 ETF Trust

$270.40

0.35 (0.13%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$41.47

0.33 (0.80%)

19:10
02/22/18
02/22
19:10
02/22/18
19:10
Hot Stocks
OMA Airports reports Q4 passenger traffic up 1.8% »

Total terminal passenger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIV

Aimco

$38.28

0.28 (0.74%)

19:05
02/22/18
02/22
19:05
02/22/18
19:05
Hot Stocks
Aimco acquires Bent Tree apartment community for $160M »

Apartment Investment and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$3.60

-0.16 (-4.26%)

18:49
02/22/18
02/22
18:49
02/22/18
18:49
Hot Stocks
Kadmon updates 'positive' results from Phase 2 study of KD025 in cGVHD »

Kadmon announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$182.83

1.49 (0.82%)

18:47
02/22/18
02/22
18:47
02/22/18
18:47
Hot Stocks
Asur reports Q4 passenger traffic down 4% »

ASUR's total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$54.27

-0.83 (-1.51%)

18:45
02/22/18
02/22
18:45
02/22/18
18:45
Periodicals
Judge criticizes U.S. Bancorp deal to sidestep prosecution, Bloomberg reports »

U.S. District Judge Lewis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 30

    May

KZIA

Kazia Therapeutics

$4.99

0.43 (9.43%)

18:36
02/22/18
02/22
18:36
02/22/18
18:36
Hot Stocks
Kazia granted orphan status for glioblastoma treatment »

The FDA granted Kazia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBE

Obsidian Energy

$0.98

0.0183 (1.91%)

18:29
02/22/18
02/22
18:29
02/22/18
18:29
Hot Stocks
Obsidian Energy reports 126% reserve replacement of 2017 production »

Obsidian Energy said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBE

Obsidian Energy

$0.98

0.0183 (1.91%)

18:27
02/22/18
02/22
18:27
02/22/18
18:27
Hot Stocks
Obsidian Energy names Jay Thornton chairman of the board »

Obsidian Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$8.33

0.06 (0.73%)

18:27
02/22/18
02/22
18:27
02/22/18
18:27
Earnings
SSR Mining reports Q4 adjusted EPS 2c, consensus 7c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SSRM

SSR Mining

$8.33

0.06 (0.73%)

18:21
02/22/18
02/22
18:21
02/22/18
18:21
Hot Stocks
SSR Mining sees 2018 gold production 340K gold equivalent ounces »

SSR Mining expect to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

IVC

Invacare

$17.97

-0.28 (-1.53%)

18:20
02/22/18
02/22
18:20
02/22/18
18:20
Hot Stocks
Invacare names Kathleen Leneghan as CFO, effective immediately »

Invacare announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SHCAY

Sharp

$8.21

-0.025 (-0.30%)

18:18
02/22/18
02/22
18:18
02/22/18
18:18
Periodicals
Sharp drops legal action against Hisense over TV brands, Nikkei reports »

Sharp has dropped legal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$40.91

0.35 (0.86%)

18:17
02/22/18
02/22
18:17
02/22/18
18:17
Periodicals
GM seeks South Korean aid to bolster local unit, Nikkei Asian Review reports »

General Motors is seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$26.34

0.23 (0.88%)

18:14
02/22/18
02/22
18:14
02/22/18
18:14
Earnings
Breaking Earnings news story on South Jersey Industries »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

TRTN

Triton International

$28.16

-0.4 (-1.40%)

18:13
02/22/18
02/22
18:13
02/22/18
18:13
Earnings
Triton International reports Q4 adjusted EPS 85c, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SJI

South Jersey Industries

$26.34

0.23 (0.88%)

18:13
02/22/18
02/22
18:13
02/22/18
18:13
Earnings
Breaking Earnings news story on South Jersey Industries »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

PAA

Plains All American

$20.97

-0.43 (-2.01%)

18:09
02/22/18
02/22
18:09
02/22/18
18:09
Hot Stocks
Plains All American's Cactus II pipeline fully committed »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

STX

Seagate

$51.36

-0.08 (-0.16%)

18:03
02/22/18
02/22
18:03
02/22/18
18:03
Initiation
Seagate initiated at Stifel »

Seagate resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

WDC

Western Digital

$85.53

-0.14 (-0.16%)

18:01
02/22/18
02/22
18:01
02/22/18
18:01
Initiation
Western Digital initiated at Stifel »

Western Digital resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$21.39

0.22 (1.04%)

17:56
02/22/18
02/22
17:56
02/22/18
17:56
Hot Stocks
Breaking Hot Stocks news story on HP Inc. »

HP Inc. sees higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 24

    Apr

  • 30

    May

BKD

Brookdale Senior Living

$7.18

-1.72 (-19.33%)

17:52
02/22/18
02/22
17:52
02/22/18
17:52
Downgrade
Brookdale Senior Living rating change at Stifel »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AQMS

Aqua Metals

$2.62

-0.25 (-8.71%)

17:52
02/22/18
02/22
17:52
02/22/18
17:52
Hot Stocks
Philotimo Fund reports 6.5% stake in Aqua Metals »

Philotimo Fund purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.